Chung YB - Search Results

1

Cytotoxic germacranolide sesquiterpene lactones from Carpesium triste var. manshuricum.

Kim MR, Hwang BY, Jeong ES, Lee YM, Yoo HS, Chung YB, Hong JT, Moon DC. Kim MR, et al. Among authors: chung yb. Arch Pharm Res. 2007 May;30(5):556-60. doi: 10.1007/BF02977648. Arch Pharm Res. 2007. PMID: 17615673

2

Effects of guanosine on the pharmacokinetics of acriflavine in rats following the administration of a 1:1 mixture of acriflavine and guanosine, a potential antitumor agent.

Lee PS, Shin DH, Lee KM, Song S, Yoo HS, Moon DC, Hong JT, Chung YB. Lee PS, et al. Among authors: chung yb. Arch Pharm Res. 2007 Mar;30(3):372-80. doi: 10.1007/BF02977621. Arch Pharm Res. 2007. PMID: 17424946

3

Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent.

Shin DH, Choi KS, Cho BS, Song S, Moon DC, Hong JT, Lee CK, Chung YB. Shin DH, et al. Among authors: chung yb. Arch Pharm Res. 2008 Oct;31(10):1347-53. doi: 10.1007/s12272-001-2116-z. Epub 2008 Oct 29. Arch Pharm Res. 2008. PMID: 18958427

4

Determination of eperisone in human plasma by liquid chromatography-ESI-tandem mass spectrometry.

Jeoung MK, Jeong ES, Kim NH, Kim CS, Chung YB, Lee YM, Ahn SY, Cho HE, Lee YH, Hong JT, Moon DC. Jeoung MK, et al. Among authors: chung yb. Arch Pharm Res. 2007 Sep;30(9):1174-8. doi: 10.1007/BF02980255. Arch Pharm Res. 2007. PMID: 17958338

5

Pharmacokinetics of 11-hydroxyaclacinomycin X (ID-6105), a novel anthracycline, after i.v. bolus multiple administration in rats.

Yoo BI, Ahan KB, Kang MH, Kwon OS, Hong YS, Lee JJ, Lee HS, Ryu JS, Kim TY, Moon DC, Song S, Chung YB. Yoo BI, et al. Among authors: chung yb. Arch Pharm Res. 2005 Apr;28(4):476-82. doi: 10.1007/BF02977679. Arch Pharm Res. 2005. PMID: 15918523

6

Revolutionizing technologies of nanomicelles for combinatorial anticancer drug delivery.

Jo MJ, Jin IS, Park CW, Hwang BY, Chung YB, Kim JS, Shin DH. Jo MJ, et al. Among authors: chung yb. Arch Pharm Res. 2020 Jan;43(1):100-109. doi: 10.1007/s12272-020-01215-4. Epub 2020 Jan 27. Arch Pharm Res. 2020. PMID: 31989478 Review.

7

Endogenous sphingolipid metabolites related to the growth in Sphingomonas chungbukensis.

Burenjargal M, Lee YS, Yoo JM, Kim YC, Lee YM, Oh S, Yun YP, Hong JT, Chung YB, Moon DC, Yoo HS. Burenjargal M, et al. Among authors: chung yb. Arch Pharm Res. 2007 Mar;30(3):317-22. doi: 10.1007/BF02977612. Arch Pharm Res. 2007. PMID: 17424937

8

Effect of excipients on the stability and transport of recombinant human epidermal growth factor (rhEGF) across Caco-2 cell monolayers.

Kim IW, Yoo HJ, Song IS, Chung YB, Moon DC, Chung SJ, Shim CK. Kim IW, et al. Among authors: chung yb, chung sj. Arch Pharm Res. 2003 Apr;26(4):330-7. doi: 10.1007/BF02976964. Arch Pharm Res. 2003. PMID: 12735693

9

Determination of recombinant human epidermal growth factor (rhEGF) in a pharmaceutical formulation by high performance liquid chromatography with electrochemical detection.

Lee KW, Hwang KH, Kim CS, Han K, Chung YB, Park JS, Lee YM, Moon DC. Lee KW, et al. Among authors: chung yb. Arch Pharm Res. 2001 Aug;24(4):355-9. doi: 10.1007/BF02975106. Arch Pharm Res. 2001. PMID: 11534771

10

Determination of recombinant human epidermal growth factor (rhEGF) in a pharmaceutical preparation by capillary electrophoresis.

Hwang KH, Lee KW, Kim CS, Han K, Chung YB, Moon DC. Hwang KH, et al. Among authors: chung yb. Arch Pharm Res. 2001 Dec;24(6):601-6. doi: 10.1007/BF02975173. Arch Pharm Res. 2001. PMID: 11794543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters